Cryo-Cell International Profit Margin

Cryo-Cell International (CCEL) currently reports a profit margin of -7.92% as of May 2026. That compares with -0.54% in the prior-year period — down 1379.6% year over year. That is below the Healthcare sector average of 13.45%. Use the charts on this page to explore Cryo-Cell International's profit margin history and peer comparisons.

Cryo-Cell International's profit margin decreased from -0.54% to -7.92% — a 1379.6% year-over-year decrease (period ending May 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cryo-Cell International's profit margin of -7.92% is lower than the Healthcare sector average of 13.45%. That is roughly 158.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Cryo-Cell International's current -7.92% should be judged against Healthcare norms (sector average: 13.45%) and against CCEL's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -7.92%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.45%. From there, open related valuation or income-statement pages for Cryo-Cell International, and consider following CCEL for alerts when major investors trade the stock.